
GC19233
LY3177833
Also known as (3R)-3-(5-fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)-2H-isoindol-1-one
LY3177833 is an CDC7 and pMCM2 inhibitor extracted from patent US 20140275131and patent WO 2014143601 A1 compound example 4; has IC50 values of 3·3 nM and 290 nM, respectively
ChemicalCAS1627696-51-8MW309.3FormulaC16H12FN5O
- CAS number
- 1627696-51-8
- Molecular weight
- 309.3
- Formula
- C16H12FN5O
- Solubility
- DMSO : ≥ 30 mg/mL (96·99 mM)
- InChIKey
- KNLVLWZENYQYRT-MRXNPFEDSA-N
- Catalogue number
- GC19233
- Brand
- GLPBIO
Computed properties PubChem CID 81689696 · XLogP 1 · TPSA 83.6 Ų · H-bond donors 2
- XLogP
- 1
- TPSA
- 83.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 23
SMILES C[C@@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F
Computed descriptors from PubChem (CID 81689696), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il